Can We Refine Criteria for the First-Line Treatment for Patients With Advanced ALK-Positive NSCLC in the Real World?
- PMID: 40484492
- DOI: 10.1016/j.jtho.2025.02.027
Can We Refine Criteria for the First-Line Treatment for Patients With Advanced ALK-Positive NSCLC in the Real World?
Conflict of interest statement
Disclosure The authors declare no conflict of interest.
Publication types
LinkOut - more resources
Full Text Sources
